Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 23 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Randomized Study of 5-FU and Thymidine vs 5-FU Alone for Adenocarcinomas of the Breast, Lung, or Colorectum and for Malignant Melanomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 70								MDA-DT-7844

Last Modified: 6/1/1998


2.		Phase III Randomized, Placebo-Controlled Study of Oral Thymidine for the Prevention of Mucositis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 to 90				NCI				CHNMC-IRB-90014 NCI-V96-1043


3.		Phase III Comparison of 5-FU vs 5-FU/PALA vs 5-FU/LEV vs 5-FU/MeCCNU/VCR/SZC vs 5-FU/TdR for Unresectable or Metastatic Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				NCCTG-804651 MAYO-804651, NCCTG-80-46-51


4.		Phase I/II Chemotherapy with ARA-C plus TdR Given by Continuous Infusion in Patients with Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								UMCC-7911


5.		Phase I/II Chemotherapy with High-Dose ARA-C plus Biochemical Modulation with PALA/Thymidine in Patients with CML in Blast Crisis and Relapsed Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				15 and over				NCI				MDA-DM-8433 NCI-T84-0418D, T84-0418

Last Modified: 9/20/2005 First Published: 6/1/1998


6.		Phase II Study of Thymidine and Carboplatin in Patients with Recurrent Malignant Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				NABTC-9705


7.		Phase II Hepatic Infusion Therapy with FUDR, MTX/TDR, NZS, ADR, BCNU, DCM for Primary or Metastatic Liver Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 70								DFCI-76050


8.		Phase II Combination Chemotherapy with Methotrexate/Thymidine for Metastatic or Unresectable Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 70								DFCI-77044


9.		Phase II Chemotherapy with PALA/TDR/5-FU for Advanced Dukes D Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 15								MDA-DT-8133


10.		Phase II Chemotherapy with PALA/5-FU/TdR for Measurable Metastatic or Recurrent Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAYO-824601 NCI-W82-1367, W82-1367

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute